Sharda Cropchem Ltd. · NSE:SHARDACROP

Sharda Cropchem — Q4 FY2025 Earnings Presentation

35 slides from Sharda Cropchem's earnings presentation, May 14, 2025

  1. Slide 1: Cover letter to stock exchanges

    WK0D\ 7R 1DWLRQDO 6WRFN ([FKDQJH RI ,QGLD %6(/LPLWHG /LPLWHG 3KLUR]H-HHMHHEKRL7RZHU ([FKDQJH3OD]DWK)ORRU3ORW1R 'DODO6WUHHW & 0XPEDL± *%ORFN%DQGUD.XUOD&RPSOH[ %DQGUD ( 0XPEDL± 7UDGLQJ6\PERO6+$5'$&523 6FULS&RGH 6XEMHFW,QYHVWRUV$QDO\VW¶V3UHVHQWDWLRQIRUWKH4XDUWHUDQG<HDUHQGHGVW 0DUFK 'HDU6LU0DGDP 3XUVXDQ

  2. Slide 2: Securing Harvests, Nurturing Lives

    é , : ox ian gone oe “a 44” ~ oc 4 s a“ ~ . : ~ a Ae ~~ 4 e ~~ is ai ate eels Lave s a AP ES Le Oe I SEOONING ALU SIESU Sp NURTUR \AS © ah : ) he ' »y } . | 5 =f if 4 | e 3 4 i oe. 2 Hof _ —— ad . , . ff . J oN *, ~~

  3. Slide 3: Safe Harbor

    SAFE HARBOR This presentation has been prepared by and is the sole responsibility of Sharda Cropchem Limited (the “Co bound by the trailing restrictions. This presentation does not constitute or form part of any offer or invitation or inducement to sell or issue, or subscribe for, any securities of

  4. Slide 4: About Sharda Cropchem

    About Sharda Cropcherr

  5. Slide 5: “W ag pe

    “W ag pe pr va an fo gl Ad Eu Am ab ra ac

  6. Slide 6: Agrochemical Focused Company

    AGROCHEMICAL FOCUSED COMPANY Sharda Cropchem is an Intellectual Property (IP) driven company engaged in marketing and distribution of wide range of formulations and generic active ingredients Asset Light Business Model : Efficiently channelizing time and resources for strengthening core competency o

  7. Slide 7: Asset Light Business Model

    ASSET LIGHT BUSINESS MODEL Overall Agrochemical Value Chain √ √ Basic & Applied Active Ingredien Identification Registration Research Manufacturing Manufacturing of AIs and Focus on identification of generic formulations is outsourced molecules, preparing dossiers, seeking registrations, marketing &

  8. Slide 8: Increasing Global Presence with Widespread Distribution

    INCREASING GLOBAL PRESENCE WIT WIDESPREAD DISTRIBUTION Presence Global Resource 80+ countries Deployment across Europe, NAFTA, LATAM & RoW 500+ Over the years, the Company has built a strong brand franchise within our global m of scale in our portfolio and leveraging value of our supply chain to del

  9. Slide 9: The Sharda Advantage

    The Sharda Advantage Global Reach Wide Product Range Quality with Faster Sales Affordability Service

  10. Slide 10: Way Forward

    WAY FORWARD 1 2 Forward Integration - Build Sales Force E 9 Leverage market presence and execution capabilities 9 Adopt the factory to farmer approach and be a one stop 9 solution provider 9 9 Strategy on ground in different regions of NAFTA, Europe, LATAM and other key markets in ROW 3 4 Continual

  11. Slide 11: Industry Outlook & Growth Drivers

    INDUSTRY OUTLOOK & GROWTH DRIV Global crop protection (In Billion USD) – CAGR of 4.3% 134.7 +4.3% A Growing Population: G and 2 billion by 2050, whil 92.2 A growing middle class fu which in turn Fewer arable acres per ca FY23 FY32e farmer yields; arable lan today to less t Source : Annual Report (FY

  12. Slide 12: Experienced Management

    Experienced Manage Mr. Ramprakash V. Bubna Mr. Ashish Bubna Chairman & Managing Director Whole Time Director 9 Holds a Bachelor’s Degree of Technology in Chemical 9 Holds a Bachelor’s Degree in Commerce from the Engineering from IIT, Bombay University of Mumbai 9 He has over 56 years of experience i

  13. Slide 13: Q4 FY25 Financial Highlights

    — r. a Q4 FY25 Financial Higt

  14. Slide 14: Q4 FY25: Segment Wise Highlights

    Q4 FY25: SEGMENT WISE HIGHLIGHTS Agrochemical Segment Non-Agrochemical Segment 93% 92% 7% 8% % +39% +42% 1,691 138 1,215 97 Q4 FY24 Q4 FY25 Q4 FY24 Q4 FY25

  15. Slide 15: Q4 FY25: Product Wise Highlights

    Q4 FY25: PRODUCT WISE HIGHLIGHTS Herbicides Insecticides Fungicides 45% 50% 18% 17% 38% 33% +57% +22% 850 +31% 557 284 458 542 216 Q4 FY24 Q4 FY25 Q4 FY24 Q4 FY25 Q4 FY24 Q4 FY25

  16. Slide 16: Q4 FY25: Region Wise Breakup (Agrochemical)

    Q4 FY25: REGION WISE BREAKUP (Agroch Europe NAFTA Region 64% 66% 28% 29% +43% +45% 1,115 493 782 340 Q4 FY24 Q4 FY25 Q4 FY24 Q4 FY25 LATAM Region RoW 3% 2% 5% 3% +19% -26% 39 60 33 44 Q4 FY24 Q4 FY25 Q4 FY24 Q4 FY25 % of Revenue

  17. Slide 17: Q4 FY25: Region Wise Breakup (Non-Agrochemical)

    Q4 FY25: REGION WISE BREAKUP (Non - A Europe NAFTA Region 17% 14% 62% 68% +19% +57% 20 94 16 60 Q4 FY24 Q4 FY25 Q4 FY24 Q4 FY25 LATAM Region RoW 5% 8% 16% 9% +142% -19% 11 16 13 5 Q4 FY24 Q4 FY25 Q4 FY24 Q4 FY25 % of Revenue

  18. Slide 18: Q4 FY25: Financial Highlights

    Q4 FY25 : FINANCIAL HIGHLIGHTS Revenues & GP Margin EBITDA 34.6% 29.8% +16.2% +39% 352 303 1,829 1,312 Q4 FY24 Q4 FY25 Q4 FY24 Q4 FY25 9 Revenue in Q4 FY25 increased by 39% primarily 9 Gross Margins are at 29.8 driven by higher volumes. We saw volume growth FY26 with prices expected to across all ma

  19. Slide 19: FY25 Financial Highlights

    FY25 Financial Highli

  20. Slide 20: FY25: Segment Wise Highlights

    FY25: SEGMENT WISE HIGHLIGHTS Agrochemical Segment Non-Agrochemical Segment 83% 87% 17% 13% % +43% +4% 3,773 547 524 2,639 FY24 FY25 FY24 FY25

  21. Slide 21: FY25: Product Wise Highlights (Agrochemical)

    FY25: PRODUCT WISE HIGHLIGHTS (Agr Herbicides Insecticides Fungicides 50% 53% 21% 19% 29% 28% +52% +38% 1,995 +28% 1,058 721 765 1,313 562 FY24 FY25 FY24 FY25 FY24 FY25

  22. Slide 22: FY25: Region Wise Breakup (Agrochemical)

    FY25: REGION WISE BREAKUP (Agrochemica Europe NAFTA Region 57% 58% 31% 33% +45% +49% 2,177 1,227 1,501 822 FY24 FY25 FY24 FY25 LATAM Region RoW 6% 5% 6% 5% +23% +11% 191 161 178 155 FY24 FY25 FY24 FY25 % of Revenue

  23. Slide 23: FY25: Region Wise Breakup (Non-Agrochemical)

    FY25: REGION WISE BREAKUP (Non - Agroch Europe NAFTA Region 16% 14% 58% 67% -9% +20% 85 77 367 305 FY24 FY25 FY24 FY25 LATAM Region RoW 6% 9% 20% 10% +55% -47% 47 103 31 55 FY24 FY25 FY24 FY25 % of Revenue

  24. Slide 24: FY25: Financial Highlights

    FY25 : FINANCIAL HIGHLIGHTS Revenues & GP Margin EBITDA 25.9% 29.9% +114.3% 682 +37% 4,320 4 320 3,163 318 FY24 FY25 FY24 FY25 9 Revenue in FY25 increased by 37% primarily driven 9 Gross Margins have incre by higher volumes and a gradual price increase. We improve in FY26 with prices e saw volume gr

  25. Slide 25: Strong Balance Sheet

    STRONG BALANCE SHEET Working Capital (in Days) 158 days 118 days 192 Reduced Working 157 Capital by 40 days 146 123 111 83 Mar-24 Mar-25 Inventory Days Recievable Days Creditor Days RoCE* RoE* 16.0% 12.8% * ROCE = EBIT / Average Capital Employed ; RoE = PAT / Average Equity

  26. Slide 26: Annexure

    Annexure

  27. Slide 27: Q4 & FY25 Financial Highlights

    Q4 & FY25 FINANCIAL HIGHLIGHTS Particulars Q4 FY25 Q4 FY24 Revenue from Operations 1,828.5 1,312.1 COGS 1,284.5 858.3 Gross Profit 544.0 453.8 Gross Margin % 29.8% 34.6% Employee Expenses 18.2 14.7 Other Expenses 233.2 165.3 EBITDA* 351.8 302.7 EBITDA Margin % 19.2% 23.1% Forex (Gain)/Loss -10.5 19.

  28. Slide 28: Balance Sheet

    BALANCE SHEET EQUITY & LIABILITIES Mar-25 Mar-24 ASSETS Equity Non-current assets Equity share capital 90.2 90.2 Property, plant and e Other equity 2,410.3 2,146.9 Right to use assets Equity attributable to equity holders of the Company 2,500.6 2,237.1 Goodwill Non-controlling interests 0.4 0.4 Tota

  29. Slide 29: Cash Flow Statement

    CASH FLOW STATEMENT Particulars Profit Before Tax Adjustments Operating profit before working capital changes Changes in working capital Cash generated from operations Direct taxes paid (net of refund) Net Cash from Operating Activities Net Cash from Investing Activities Net Cash from Financing Acti

  30. Slide 30: Key Financial Performance Indicators

    KEY FINANCIAL PERFORMANCE INDIC Revenue EBITDA & EBITDA Margin* 19.0% 20.4% 17.6% 10.1% 15.8% 4,045 4,320 3,580 3,163 729 713 68 2,396 455 318 FY21 FY22 FY23 FY24 FY25 FY21 FY22 FY23 FY24 FY2 RoCE RoE 25.7% 19.8% 20.2% 20.8% 15.2% 16.5% 16.0% 12.8 3.4% 1.4% FY21 FY22 FY23 FY24 FY25 FY21 FY22 FY23 FY

  31. Slide 31: Historical Profit & Loss

    HISTORICAL PROFIT & LOSS Particulars FY25 FY24 Revenue from Operations 4,319.9 3,163.0 COGS 3,028.1 2,342.4 Gross Profit 1,291.8 820.6 Gross Margin % 29.9% 25.9% Employee Expenses 52.0 42.4 Other Expenses 626.3 494.9 EBITDA* 681.6 318.1 EBITDA Margin % 15.8% 10.1% Forex (Gain)/Loss 17.9 0.4 Deprecia

  32. Slide 32: Balance Sheet – Equity & Liabilities

    BALANCE SHEET – EQUITY & LIABILITIE Equities & Liabilities FY25 FY24 Shareholder's Funds Equity and Share Capital 90.2 90.2 Other Equity 2,410.4 2,146.9 Non-controlling Interest 0.4 0.4 Total Equity 2,501.0 2,237.5 Non-Current Liabilities Borrowings - - Trade Payables - - Lease Liabilities - 7.8 Oth

  33. Slide 33: Balance Sheet – Assets

    BALANCE SHEET – ASSETS ASSETS FY25 FY24 Assets Non-Current Assets Property, Plant and Equipment 3.0 3.8 Right to Use Assets 7.2 14.4 Goodwill 0.0 0.0 Other Intangible assets 740.2 690.0 Intangible assets under development 291.4 282.9 Deferred Tax Assets (net) 11.6 10.3 Non-Current Tax Assets 63.4 72

  34. Slide 34: CSR Activities

    CSR ACTIVITIES CSR initiatives taken up by the Company are in the areas of Promoting Education, Women, Animal Welfare, Promotion of Sports and Rural Promoting Education Animal Welfare

  35. Slide 35: Thank You

    SECURING HARVESTS, NURTU THANK YOU Company: y Sharda Cropchem p Limited Investor Relation A CIN: L51909MH2004PLC145007 CIN Mr. Shailesh Mehendale – CFO cfo@shardaintl.com / finance@shardaintl.com Tel: +91 22 6678 2800

Sharda Cropchem — Q4 FY2025 Earnings Presentation on 6ix